MetLife Inc., US59156R1086

MetLife stock faces legacy-policy fallout after C$213.5M settlement

Published on 11/02/2026 at 16:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
MetLife stock is back in focus after a Canadian court approved a legacy-policy settlement. The company reports third-quarter results on Wednesday.

Legacy liabilities and upcoming results

  • A Canadian court approved a settlement involving policies originally sold by MetLife agents.
  • The arrangement limits selected future insurance charges and administration fees for eligible policyholders.
  • MetLife is due to release third-quarter results after the US market close on November 4.
MetLife Inc., US59156R1086, Illustration mit AI erstellt.

MetLife stock is facing renewed attention over legacy Canadian insurance policies after the Ontario Superior Court of Justice approved a C$213.5 million settlement on October 27. The agreement covers policies originally sold by Metropolitan Life Insurance Co. between 1985 and 1998, according to Advisor.ca.

Settlement puts legacy policies in focus

About 70,000 current and former policyholders are eligible for benefits under the arrangement. The case concerns policies administered by Sun Life after it acquired Clarica Life Insurance Co.; Clarica had acquired MetLife's Canadian operations in 1998.

Eligible Flexiplus policyholders are set to receive compensation for part of past cost-of-insurance and administration-fee increases. For current policyholders, those charges will be permanently frozen. Certain current and former holders of pre-1992 Universal Plus policies will receive compensation for charges above specified premium limits, while future cost-of-insurance charges will be capped for eligible current holders.

Sun Life has denied wrongdoing. Advisor.ca reported that MetLife provided an indemnity covering the policies and that Sun Life had said it would seek recovery from MetLife if the settlement received approval. That provision keeps the potential financial exposure linked to the former Canadian business relevant for investors, although the settlement itself does not establish a new earnings impact for MetLife.

Results arrive this week

MetLife will release third-quarter 2026 results after the US market close on Wednesday, November 4, and hold its earnings call on Thursday, November 5, according to the company's announcement. The report will give investors the next scheduled opportunity to assess operating performance alongside the renewed focus on historic policy liabilities.

MetLife stock traded at 89.79 euros on Lang & Schwarz at 16:13 CET on Monday, November 2. The real-time quote of MetLife stock is available separately.

MetLife Inc. stock facts

  • Company: MetLife Inc.
  • ISIN: US59156R1086
  • WKN: 934623
  • Home exchange: New York Stock Exchange
  • Lang & Schwarz price: 89.79 euros at 16:13 CET on November 2, 2026
  • Settlement: C$213.5 million approved on October 27, 2026

Broader market conditions remain relevant for US-listed insurers; see the latest S&P 500 market coverage.

For more company-specific developments, see more news and analyses on MetLife stock.

Disclaimer...
en | US59156R1086 | METLIFE INC. | boerse | 70446486 |